UK vaccinates 6m as toll nears 100,000
LONDON: Britain is expanding a coronavirus vaccination programme that has seen more than 6 million people get the first of two doses - even as the country’s death toll in the pandemic approaches 100,000.
Health Secretary Mat Hancock said Sunday that three-quarters of the UK’S over-80s have received a vaccine shot.
He said three-quarters of nursing home residents have also had their first jab.
Health authorities said 6.35 million doses of vaccine have been administered since injections began last month, including almost 500,000 doses on Saturday, the highest one-day total so far.
Health officials aim to give 15 million people, including everyone over 70, a first vaccine shot by Feb.15, and cover the entire adult population by September.
Britain is inoculating people with two vaccines - one made by US pharma firm Pfizer and German company Biontech, the other by Uk-swedish drugmaker Astrazeneca and Oxford University.
It has also authorised a third, developed by Moderna.
It is giving the shots at doctors’ offices, hospitals, pharmacies and vaccination centers set up in conference halls, sports stadiums and other large venues like Salisbury Cathedral.
Thirty more locations are opening this week, including a former IKEA store and a museum of industrial history that was used as a set for the TV show “Peaky Blinders.”
Britain’s vaccination campaign is a rare success in a country with Europe’s worst confirmed coronavirus outbreak.
The UK has recorded 97,939 deaths among people who tested positive, including 610 new deaths reported on Sunday.
The UK is set within days to become the fith country in the world to record 100,000 COVID-19 deaths, ater the United States, Brazil, India and Mexico - all of which have much larger populations than Britain’s 67 million people.
Some health experts have questioned the Conservative government’s decision to give the two vaccine doses up to 12 weeks apart, rather than the recommended three weeks, in order to offer as many people as possible their first dose quickly.
Astrazeneca has said it believes a first dose of its vaccine offers protection ater 12 weeks but Pfizer says it has not tested the efficacy of its jab ater such a long gap.